Shlomo Melmed
Director/Board Member at Prometheus Laboratories, Inc.
Profile
Shlomo Melmed is currently a Director at Prometheus Laboratories, Inc., Visby Medical, Inc., and Emulate, Inc. He was formerly a Director at Prometheus Biosciences, Inc.
Shlomo Melmed active positions
Companies | Position | Start |
---|---|---|
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Director/Board Member | - |
Emulate, Inc.
Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Director/Board Member | - |
Former positions of Shlomo Melmed
Companies | Position | End |
---|---|---|
PROMETHEUS BIOSCIENCES, INC. | Director/Board Member | 2020-09-28 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
Prometheus Laboratories, Inc.
Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Health Technology |
Emulate, Inc.
Emulate, Inc. Drugstore ChainsRetail Trade Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA. | Retail Trade |
Visby Medical, Inc.
Visby Medical, Inc. BiotechnologyHealth Technology Visby Medical, Inc. operates as a healthcare technology company. It develops diagnostic products for professionals and consumers. The company was founded by Gregory Loney and Adam de la Zerda in 2008 and is headquartered in San Jose, CA. | Health Technology |
- Stock Market
- Insiders
- Shlomo Melmed